Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × Immune Checkpoint Inhibitors × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 20 Carcinoma, Hepatocellular 11 Neoplasms 7 Melanoma 7 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Colonic Neoplasms 5 Nasopharyngeal Carcinoma 4 Colorectal Neoplasms 4 Small Cell Lung Carcinoma 3 Recurrence 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Renal Cell 3 Solid Cancers 2 Skin Neoplasms 2 Prostatic Neoplasms 2 Pathologic Complete Response 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Gastric / Gastroesophageal Junction Adenocarcinoma 2 Esophageal Squamous Cell Carcinoma 2 EBV-associated Tumors 2 Breast Neoplasms 2 Bites and Stings 2

Interventions

Cyclophosphamide 80 Rituximab 77 Prednisone 45 Doxorubicin 39 Lenalidomide 35 Vincristine 32 fludarabine 27 polatuzumab vedotin 25 Magnetic Resonance Spectroscopy 24 Gemcitabine 23 Etoposide 23 Specimen Handling 22 Oxaliplatin 19 Biopsy 18 CT-P10 17 glofitamab 15 zanubrutinib 14 ibrutinib 13 fludarabine phosphate 13 tafasitamab 12 obinutuzumab 12 axicabtagene ciloleucel 12 venetoclax 10 pembrolizumab 10 deltacortene 10 Bendamustine Hydrochloride 10 prednylidene 9 Prednisolone 9 Nivolumab 9 Immunotherapy, Adoptive 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡